Ocera Starts Second Part of Trial of OCR-002 for Liver Disease That Impacts Mental Functioning
Ocera Therapeutics has started the second part of a Phase 1/2a clinical trial of OCR-002 (ornithine phenylacetate) tablets as a treatment for a liver…
Liver disease
Australian Researchers Investigate Zinc as Potential Ally Against Liver Disease
A study by Australia’s Westmead Institute has revealed an unexpected role for zinc in liver disease. Researchers at the institute’s Storr Liver Center showed that…
Recent Posts
- A new tool may help predict your future with liver disease
- ALF unveils network to connect living donors with strangers in need
- Drug combo shrinks liver fat in rats and zebrafish: Study
- Know your risks – and options – this National Liver Awareness Month
- Enrollment complete in 2 Phase 2 trials testing hepatitis B treatment